PsiQuantum has announced a groundbreaking collaboration with the National Cancer Center Japan, a leading hub for cancer treatment and research, aiming to harness utility-scale quantum computers to transform oncology and healthcare.
The partnership will focus on advancing fault-tolerant quantum algorithms and developing clinically relevant quantum applications in collaboration with Japan’s top pharmaceutical companies. Central to the effort is PsiQuantum’s Construct software suite, a secure, end-to-end platform for designing, analyzing, and optimizing algorithms for fault-tolerant quantum computing.
“PsiQuantum is proud to work alongside the National Cancer Center Japan as we explore what utility-scale quantum computing will be able to deliver in designing new treatments for the benefit of researchers and patients,” said Sam Pallister, PsiQuantum’s Vice President for Quantum Applications.
“Once deployed, utility-scale quantum computers will accelerate research and development that transforms how we develop new medicines—and partnerships like these are critical for making sure providers are equipped to take full advantage of this technology.”
Takayuki Yoshino, Director of the Department of Global Oncology at the National Cancer Center Hospital East in Kashiwa, Japan, added: “We are thrilled to partner with PsiQuantum on leveraging quantum computing technology to address some of the most pressing challenges in healthcare. Together, our teams are poised to conduct innovative research and unlock new solutions at the intersection of pharmaceuticals, biotechnology, and quantum computing.”
Currently, developing new pharmaceutical treatments is a slow, costly process, and traditional computing methods often fall short in producing reliable, actionable results. Utility-scale quantum computers promise to change that by simulating molecular systems with unprecedented speed, scale, and accuracy.
By delivering chemically precise simulations faster, these quantum systems could accelerate drug discovery, reduce R&D costs, and help healthcare providers tackle real-world challenges more effectively.
